Prospective students          Students           Collaborations    

A review article on antibody Fc engineering technology is recently published by Laboratory of Antibody Engineering in the journal Frontiers in Immunology

Author: SIAIS

Time: 18 December 2016

An invited review article entitled Advances in therapeutic Fc engineering - modulation of IgG associated effector functions and serum half-life has recently been published in Frontiers in Immunology journal. This review article has been contributed by Dr. Abhishek Saxena as the first author (Senior Postdoctoral Fellow; Laboratory of Antibody Engineering, SIAIS) and Research Associate Prof. Donghui Wu as the correspondence author (Co-PI; Laboratory of Antibody Engineering, SIAIS). In this article, the authors summarize the recent advances in Fc linked effector functions including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and antibody-dependent cell-mediated phagocytosis (ADCP) and serum half-life for cancer treatment. The authors also discuss the progress made in aglycosylated mAb development that may substantially reduce the cost of manufacture but maintain similar efficacies as conventional glycosylated mAb. Finally, the authors highlight several Fc engineering-based mAbs under clinical trials.

Structural representation of key residues involved in Fc-FcRs/FcRn interactions

Saxena A and Wu D (2016) Advances in Therapeutic Fc Engineering C Modulation of IgG-Associated Effector Functions and Serum Half-life. Front. Immunol. 7:580. doi: 10.3389/fimmu.2016.00580


Y Building, No. 393 Middle Huaxia Road, Pudong, Shanghai, 201210

Copyright © 2018 Shanghai Institute for Advanced
Immunochemical Studies Institute of ShanghaiTech All rights reserved